Rare diseases
Investigational molecules
Locations
Am Klopferspitz 19, Martinsried, 82152 Planegg, Germany
CatalYm GmbH focuses on clinical research in advanced-stage solid tumors and relapsed/refractory cancer, with activity across multiple difficult-to-treat settings.
The sponsor’s oncology portfolio also includes patients with prior anti-PD-1/PD-L1 treatment exposure and limited remaining standard options.
CatalYm GmbH runs clinical trials in conditions such as Cachexia, Hepatocellular carcinoma, Non-small cell lung cancer, Bladder cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
FranceGermany
ItalyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
